What is the current RNA Sequencing Analysis market size?

The RNA Sequencing Analysis market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the RNA Sequencing Analysis market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in technology.

What are the major challenges facing the RNA Sequencing Analysis market?

Challenges include high costs of sequencing, data analysis, and storage, as well as regulatory hurdles.

Which regions are expected to lead the RNA Sequencing Analysis market?

North America and Europe are expected to dominate the market due to strong research infrastructure.

Who are the top companies in the RNA Sequencing Analysis market?

Top companies include Illumina, Thermo Fisher, and Agilent, offering a range of sequencing platforms.

What future opportunities exist in the RNA Sequencing Analysis market?

Future opportunities include single-cell analysis, liquid biopsy, and non-coding RNA research, driving future outlook.

How is technology impacting the RNA Sequencing Analysis market?

Advances in sequencing technologies, such as nanopore sequencing, are increasing efficiency and reducing costs.

What is the current regulatory landscape for the RNA Sequencing Analysis market?

Regulatory bodies, such as the FDA, are establishing guidelines for clinical use of RNA sequencing, ensuring safety and efficacy.

How will the RNA Sequencing Analysis market evolve in the next 5 years?

The market will evolve through increased adoption of sequencing in clinical settings, driving growth and innovation.

RNA Sequencing Analysis Growth Trends & Strategic Outlook 2033

RNA Sequencing Analysis by Application (Research Institutions, Bioscience Companies, Others), by Types (Total RNA, Pre-mRNA, Noncoding RNA), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

RNA Sequencing Analysis Market Size | CAGR 12.8 Forecast 2033

RNA Sequencing Analysis Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

RNA Sequencing Analysis Market Overview

The RNA Sequencing Analysis market refers to the process of determining the order of nucleotides in RNA molecules, which is crucial for understanding gene expression and regulation. As a key component of the genomics and transcriptomics landscape, the RNA Sequencing Analysis market size is estimated to be around $4.8 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 13.2% during the forecast period from 2026 to 2033. This industry expansion is driven by advances in sequencing technologies, increasing demand for personalized medicine, and growing investments in genomic research. The scope of this market encompasses various sequencing platforms, data analysis software, and services offered by companies and research institutions.

Loading chart…

The North American region is the largest market for RNA Sequencing Analysis, driven by the presence of major biotechnology and pharmaceutical companies. The Asia-Pacific region is expected to be the fastest-growing market, driven by increasing investments in genomic research and precision medicine. Key forces shaping the industry include technology shifts towards single-cell sequencing, regulatory frameworks governing genetic data, and competitive intensity among sequencing platform providers. As the market continues to evolve, companies must navigate these forces to capitalize on emerging opportunities and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	31.45 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; Bio-Rad; Roche; Pacific Biosciences; Agilent Technologies; QIAGEN
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The RNA Sequencing Analysis market is poised for significant growth, driven by factors such as the increasing adoption of precision medicine and the rising demand for RNA Sequencing Analysis market size expansion. The growth forecast for this market is promising, with key players investing heavily in research and development to capitalize on emerging trends.

Growth Drivers2 items

Advances in RNA Sequencing Analysis technology have led to improved accuracy and reduced costs, making it more accessible to researchers and clinicians, thereby driving growth in the RNA Sequencing Analysis market.

Government initiatives and funding for genomics research have increased, providing a boost to the RNA Sequencing Analysis market size and encouraging innovation in this field.

Restraints2 items

The high cost of RNA Sequencing Analysis equipment and reagents, as well as the need for specialized expertise, can limit adoption in resource-constrained settings, affecting the growth forecast of the market.

Concerns regarding data privacy and security in RNA Sequencing Analysis can hinder the willingness of patients and institutions to participate in research studies, potentially slowing market growth.

Opportunities2 items

The increasing use of RNA Sequencing Analysis in non-invasive diagnostics and liquid biopsies presents a significant opportunity for market expansion, particularly in the context of cancer and rare disease research.

Partnerships between academic institutions, research organizations, and industry players can facilitate the development of new RNA Sequencing Analysis applications and drive growth in the market.

Challenges2 items

The complex regulatory landscape surrounding RNA Sequencing Analysis, including issues related to test validation and reimbursement, can pose challenges for market players aiming to commercialize their products.

The need for standardized protocols and data analysis pipelines in RNA Sequencing Analysis can hinder comparability across studies and slow the translation of research findings into clinical practice, affecting the RNA Sequencing Analysis market size.

Market Segmentation

Loading chart…

The Application segment of the RNA Sequencing Analysis market is divided into various categories, including diagnostic and research applications. This segmentation contributes significantly to the overall market size, as different applications have distinct requirements and drive demand for specific types of RNA sequencing analysis. Understanding the application segment is crucial for RNA Sequencing Analysis segmentation, as it helps identify areas with high growth potential and informs business strategies.

The Types segment of the RNA Sequencing Analysis market encompasses several subtypes, such as small RNA sequencing, mRNA sequencing, and total RNA sequencing. Each subtype has its own set of applications and requirements, influencing the overall market size. Analyzing the types segment provides valuable insights into the market taxonomy, enabling stakeholders to make informed decisions about investments and resource allocation. By examining the types segment, businesses can identify opportunities to develop specialized solutions and capitalize on emerging trends in the RNA Sequencing Analysis market.

RNA Sequencing Analysis Segmentation Breakdown8 items

Application

Research Institutions

Bioscience Companies

Others

Types

Total RNA

Pre-mRNA

Noncoding RNA

Regional Insights

Loading chart…

The RNA Sequencing Analysis market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of RNA sequencing technologies, favorable policies, and significant investments in research and development.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large patient population with access to advanced healthcare facilities. In Europe, drivers include a strong pharmaceutical industry, significant research funding, and a high level of ecosystem maturity. Asia Pacific is driven by a large and growing demographics, increasing adoption of RNA sequencing technologies, and rising investments in healthcare infrastructure.

Latin America and Middle East & Africa are expected to experience moderate RNA Sequencing Analysis market growth, driven by increasing awareness of RNA sequencing technologies, improving infrastructure, and growing demand for advanced healthcare services. Overall, the regional forecast indicates a diverse landscape, with each region presenting unique opportunities and challenges for market players.

Competitive Landscape

The RNA Sequencing Analysis market is moderately consolidated, with a mix of global players and local/regional companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The RNA Sequencing Analysis competitive landscape is characterized by high competition, with key players focusing on differentiation through innovative products, services, and strategic partnerships. Global players have a significant presence, but local companies are also making inroads, particularly in emerging markets.

Companies in this space are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode profitability. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are notable for their strategic focus:

Illumina: regional expansion

Thermo Fisher Scientific: innovation pipeline

Bio-Rad: OEM tie-ups

Roche: premium pricing

Pacific Biosciences: vertical integration

Agilent Technologies: local manufacturing

Key RNA Sequencing Analysis Companies7 items

Illumina

Thermo Fisher Scientific

Bio-Rad

Roche

Pacific Biosciences

Agilent Technologies

QIAGEN

Market Ecosystem

The RNA Sequencing Analysis ecosystem spans across upstream, midstream, and downstream components, involving various stakeholders who contribute to the creation and capture of value. Technology providers and suppliers form the upstream segment, while integrators and channels constitute the midstream. End users, including research institutions and pharmaceutical companies, are the primary beneficiaries of the downstream segment. The ecosystem's value chain is intricate, with each participant influencing the overall efficiency and effectiveness of RNA Sequencing Analysis.

Raw material/component suppliers — provide sequencing reagents

Technology providers — develop sequencing platforms

System integrators / EPCs — integrate sequencing systems

Distributors / channel partners — supply sequencing equipment

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize sequencing data for research

Regulators/standards bodies — establish sequencing standards

In the RNA Sequencing Analysis ecosystem, control points are primarily held by technology providers and regulators, who influence adoption through platform development and standardization. Dependency risks arise from input constraints, such as sequencing reagent availability, and standards approvals. Switching costs and partnerships also play a crucial role, as end users often invest heavily in specific sequencing platforms. The ecosystem differs by region, with varying levels of investment in sequencing infrastructure and distinct regulatory frameworks. Understanding the RNA Sequencing Analysis ecosystem is essential for navigating these complexities and identifying opportunities for growth and innovation.

Recent Industry Insights

The RNA Sequencing Analysis industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between Illumina and Bristol Myers Squibb, have been formed to advance the field of genomics and improve cancer treatment. Additionally, there have been several mergers & acquisitions, including the acquisition of PacBio by Illumina, which is expected to enhance the company's sequencing capabilities.

Furthermore, the industry has seen several product/technology launches, such as the introduction of Oxford Nanopore's PromethION platform, which offers high-throughput sequencing capabilities. Regulatory changes, including the FDA's updated guidelines for next-generation sequencing, have also impacted the industry. These developments, along with funding rounds and expansions, are driving growth in the RNA Sequencing Analysis market and shaping its future.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the RNA Sequencing Analysis market. The market attractiveness is high due to its increasing applications in personalized medicine and cancer research. The competitive intensity is moderate, with key players focusing on innovative technologies and strategic partnerships. The long-term outlook for the RNA Sequencing Analysis market outlook is promising, driven by advancements in sequencing technologies and growing demand for precision medicine. However, the demand–supply balance may be affected by key risk factors, including regulatory challenges and high equipment costs.

11 items

1. Executive Summary

2. RNA Sequencing Analysis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global RNA Sequencing Analysis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global RNA Sequencing Analysis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Research Institutions

6.1.2. Bioscience Companies

6.1.3. Others

6.2. Global RNA Sequencing Analysis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Total RNA

6.2.2. Pre-mRNA

6.2.3. Noncoding RNA

6.3. Global RNA Sequencing Analysis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global RNA Sequencing Analysis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global RNA Sequencing Analysis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global RNA Sequencing Analysis Market Competition by Key Manufacturers

8.1. Global RNA Sequencing Analysis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global RNA Sequencing Analysis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Illumina

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Pacific Biosciences

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Agilent Technologies

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. QIAGEN

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global RNA Sequencing Analysis Market

Figure 4: Global RNA Sequencing Analysis Market: Drivers

Figure 5: Global RNA Sequencing Analysis Market: Challenges

Figure 6: Global RNA Sequencing Analysis Market: Trends

Figure 7: Global RNA Sequencing Analysis Market: Opportunity

Figure 8: Global RNA Sequencing Analysis Market: Restraint

Figure 9: Global RNA Sequencing Analysis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global RNA Sequencing Analysis Market Value (USD Million) By Region

Figure 15: Global RNA Sequencing Analysis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global RNA Sequencing Analysis Market Value (USD Million) By Region

Figure 23: Global RNA Sequencing Analysis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global RNA Sequencing Analysis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global RNA Sequencing Analysis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global RNA Sequencing Analysis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global RNA Sequencing Analysis Market Value (USD Million) By Region

Table 10: Global RNA Sequencing Analysis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global RNA Sequencing Analysis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global RNA Sequencing Analysis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global RNA Sequencing Analysis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Illumina Basic Information And Sales Area

Table 31: Illumina. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Bio-Rad Basic Information And Sales Area

Table 35: Bio-Rad. Products Portfolio

Table 36: Roche Basic Information And Sales Area

Table 37: Roche. Products Portfolio

Table 38: Pacific Biosciences Basic Information And Sales Area

Table 39: Pacific Biosciences. Products Portfolio

Table 40: Agilent Technologies Basic Information And Sales Area

Table 41: Agilent Technologies. Products Portfolio

Table 42: QIAGEN Basic Information And Sales Area

Table 43: QIAGEN. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global RNA Sequencing Analysis Market Value (USD Million) By Region

Table 49: Global RNA Sequencing Analysis Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

RNA Sequencing Analysis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	31.45 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; Bio-Rad; Roche; Pacific Biosciences; Agilent Technologies; QIAGEN
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options